Jump to content

Talk:Amgen

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by JZindler (talk | contribs) at 20:21, 17 April 2023 (COI Edit Request April 2023). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Removal of certain "key people" from infobox

  • Chad Carlile: this person is not listed on the Amgen.com website.
    • The inclusion of this person is presumably based on information found in the Fall 2004 APSA Newsletter (see http://www.psychology.sdsu.edu/APSA_News_F-04.pdf) in which his role is described as follows: "Within Amgen, Chad works as a Senior Curriculum Designer at the organization’s headquarters in Thousand Oaks, CA. His group is part of a larger training function in the organization that trains new and existing employees on task- and product-specific qualities."
    • Removing this piece of information is a matter of addressing notability of content
  • Mark Hutt, Pritesh Patel: these people are not listed on the Amgen.com website.
    • I have not been able to find information that links a "Mark Hutt" or "Pritesh Patel" or "Hutt" or "P. Patel" to Amgen through basic searches with Google
    • Removing this piece of information is a matter of addressing verifiability of content

Courtland 04:34, 8 November 2005 (UTC)[reply]

Article search redirects to AMGEN

I am wondering if someone might know the reasoning why a search for "Immunex" redirects to this Amgen article? I ask this because Immunex (a Biotech R&D company) was founded in the 1980's and had quite a notable history of accomplishments before it was acquired by Amgen in 2001. If no one has any objections, I would like to set up an Immunex article, which can, of course, redirect the reader to the Amgen article, should they want to read more about the company by whom Immunex was acquired. Does anyone know how I can find out if there was formerly a Wiki article on Immunex? Thank you kindly. Tell someone (talk) 02:00, 4 April 2009 (UTC)[reply]

Remove?

This looks more like advertisement than en encyclopaedial article. — Preceding unsigned comment added by Siriussounds (talkcontribs) 11:35, 9 February 2011 (UTC)[reply]

The way to deal with that is to add more WP:NPOV material critical of the company, maybe in a "Criticism" section. Here's a couple http://www.nytimes.com/2011/10/25/health/25amgen.html http://www.nytimes.com/2013/01/20/us/medicare-pricing-delay-is-political-win-for-amgen-drug-maker.html?hp&_r=0&gwh=9634789278CF43115AE6C27876406B86&pagewanted=all --Nbauman (talk) 02:47, 20 January 2013 (UTC)[reply]
The article has gone too far the other way now, the criticism section is the largest section of the article. And realistically the Sensipar trial can hardly be considered criticism - clinical trials have deaths. The wording alone is ambiguous; Sensipar is still available for use, it was dosages in children with ESRD that were being tested. Mc8755 (talk) 23:01, 1 May 2013 (UTC)[reply]

Agreed article is now mainly a timeline that has no NPOV at all. Article needs a rewrite for content and POV — Preceding unsigned comment added by 86.44.4.67 (talk) 18:28, 7 October 2013 (UTC)[reply]

Cyberbot II has detected that page contains external links that have either been globally or locally blacklisted. Links tend to be blacklisted because they have a history of being spammed, or are highly innappropriate for Wikipedia. This, however, doesn't necessarily mean it's spam, or not a good link. If the link is a good link, you may wish to request whitelisting by going to the request page for whitelisting. If you feel the link being caught by the blacklist is a false positive, or no longer needed on the blacklist, you may request the regex be removed or altered at the blacklist request page. If the link is blacklisted globally and you feel the above applies you may request to whitelist it using the before mentioned request page, or request it's removal, or alteration, at the request page on meta. When requesting whitelisting, be sure to supply the link to be whitelisted and wrap the link in nowiki tags. The whitelisting process can take its time so once a request has been filled out, you may set the invisible parameter on the tag to true. Please be aware that the bot will replace removed tags, and will remove misplaced tags regularly.

Below is a list of links that were found on the main page:

  • http://www.pharmaceutical-business-review.com/companies/amgen_inc
    Triggered by -business-review\.com\b on the local blacklist

If you would like me to provide more information on the talk page, contact User:Cyberpower678 and ask him to program me with more info.

From your friendly hard working bot.—cyberbot II NotifyOnline 17:05, 8 December 2013 (UTC)[reply]


Amgen Center for Science Learning

California Science Center article shows "Amgen Center for Science Learning", another wiki editor thought it was irrelevant on Amgen article and deleted it. Please discuss in Talk if compelled to further discuss this simple addition. Just trying to expand the better an article since another article already mentions it. Neoking (talk) 23:39, 3 February 2016 (UTC)[reply]

Thanks for opening a discussion on Talk. The most important issue I had, is that source does not describe it as a separate building. Separately, it is also trivial with regard to everything Amgen does. Why is it important from your perspective? If there were an independent source about it (coverage in a newspaper or something) you would have a stronger case to make; it is difficult with a source like this to justify it.Jytdog (talk) 23:44, 3 February 2016 (UTC)[reply]
Please do work this through, thanks. No reason to get upset, just talk it through! Jytdog (talk) 01:21, 4 February 2016 (UTC)[reply]
Here is what the source you are citing says: "The Wallis Annenberg Building houses eight classrooms, administrative offices, a multi-purpose room and the school library. In addition, the Wallis Annenberg building includes over 80,000 square feet for the Science Center’s education division, the Amgen Center for Science Learning." This makes it really clear that the Amgen Center for Science Learning is inside the Wallis Annenberg Building" Now maybe that doesn't match reality (I don't know, i have never been there) but that is what the source you have provided says. Jytdog (talk) 01:23, 4 February 2016 (UTC)[reply]
by the way, here is the content you wanted to add: ""Amgen Center for Science Learning", an Amgen Sponsored Building in California Science Center. [1]"
Do you see that you describe it as an "Amgen Sponsored Building"? (I am unsure what is up with the Germanic spelling, and I don't know why you put this in the external links section, and as I said above this would really need some kind of independent sourcing to show it is important enough to give any weight to....) but the key issue is that it is just wrong, based on the source. Jytdog (talk) 01:55, 4 February 2016 (UTC)[reply]
Its funny how someone who thinks they are a Wikipedia Editor and don't know how to use Google Maps or MapQuest or the like to verify Wallis Annenberg Building (USC) is 2 blocks North of California Science Center/Exposition Park and not what I cited. But, its ok you can sit and guard dog your page and keep being a WikiTroll, ignorance is an excuse for reverting other peoples work. So you win by default, also its only a small contribution I tried to make. There are plenty of sources showing Amgen contributions. https://students.ucsd.edu/sponsor/amgen/#Other-Amgen-centers and there are plenty of online articles about Amgen generous donation to California Science Center and Dr. Theodore T. Alexander, Jr. Science Center School its easy to make others work but not do the work yourself. You can keep guard dogging your page all you want. Wikepedia is no longer a viable scholarly source due to people like you Jytdog. Its a shame how you feel so strongly about this article, have fun sitting on it. Neoking (talk) 16:50, 4 February 2016 (UTC)[reply]
everything in WIkipedia is based on sources. I have reacted to the sources you brought and even quoted it above. You are not dealing with what it says, and I don't know what to do about that. I understand you are not happy with what it says but that is weird because you are the one who brought it. I just don't know what to do with that. Jytdog (talk) 17:53, 4 February 2016 (UTC)[reply]

COI edit request re: Russian controversy

Hi! I'm a conflict of interest editor for Amgen, a client of my employer, Porter Novelli. I have a quick edit request for this article: removing the “Controversy” paragraph about Amgen’s presence in Russia. Here’s my thinking:

  • The Yale report is a primary source, so ideally it should be supported by secondary media coverage of the same information (e.g. as in Emirates (airline)). I couldn’t find any independent media sources covering any kind of backlash or criticism against Amgen for its inclusion in the report.
  • I looked up many of the other organizations listed in the report, and from what I can tell, the only other organizations on the list with mentions in their articles had them added by either the same IP user who added the section to this article or Diuuuuu, who added almost identical wording to several more articles. All of these edits date back to April 28/29, and I didn’t see any substantive discussion in talk in the few weeks since about use of the Yale source. There is some inconclusive discussion of the source at Talk:Corporate responses to the 2022 Russian invasion of Ukraine, where DmitryShpak contends, "Yale team obviously did a lot of similar work and their list is over 450 records (some non-companies), BUT no links to company profile, expanded details, or citations make their list ambiguous at best."
  • If the reference is retained, I request that the phrase "Amgen refused to join the international community" be revised or deleted as interpretation of the source, since the source simply states that Amgen is still operating in Russia.
  • Additionally, if the reference is retained, two pieces of context I believe are relevant to include:
    • Amgen has donated $500,000 in disaster relief grants to International Medical Corps and Project Hope and provided matching funds for employee donations to select charities supporting humanitarian efforts in Ukraine.[1][2][3]
    • Many pharmaceutical companies have opted to continue operations in Russia or to suspend only some operations[4] in order to provide healthcare products and medicine to Russian people.[5]

Thanks for your time and assistance! Mary Gaulke (talk) 16:29, 17 May 2022 (UTC)[reply]

References

  1. ^ Bradway, Bob (3 March 2022). "Message from Amgen CEO Bob Bradway on Ukraine and Amgen Foundation Grant". Amgen. Retrieved 17 May 2022.
  2. ^ "Pharmaceutical industry response to the war in Ukraine". European Federation of Pharmaceutical Industries and Associations. 10 March 2022. Retrieved 17 May 2022.
  3. ^ Kansteiner, Fraiser (20 April 2022). "AbbVie joins roster of Big Pharmas donating Russian profits as war in Ukraine rages on". Fierce Pharma. Retrieved 17 May 2022.
  4. ^ Emerson, Jakob (15 April 2022). "US healthcare companies are still operating in Russia — others have left altogether". Becker's Hospital Review. Retrieved 17 May 2022.
  5. ^ Dunn, Catherine (11 March 2022). "U.S. pharma companies are staying in Russia as other industries exit". The Philadelphia Inquirer. Retrieved 17 May 2022.
 Not done for now: The paragraph is appropriate given the circumstances, so this is denied. However, it could use some improvement. Quetstar (talk) 00:43, 19 May 2022 (UTC)[reply]
@Quetstar: Thanks for the response! Would you please clarify how the paragraph is appropriate, given the concerns I raised about interpretation of a primary source? I want to understand what I'm missing here. Also, is there anything I can do to facilitate the improvement? Mary Gaulke (talk) 16:56, 19 May 2022 (UTC)[reply]
The paragraph is appropriate in the sense that it describes Amgen's stance on Russia amidst its illegal invasion of Ukraine. Removing it would basically constitiute whitewashing. As for the improvements, the text should be reformatted to make it more compliant to standards. Quetstar (talk) 11:04, 20 May 2022 (UTC)[reply]
@Quetstar: Understood. How about something like this?
During the 2022 Russian invasion of Ukraine, Amgen was one of several pharmaceutical companies that opted to continue operations in Russia.[1][2] Research from Yale University updated on April 28, 2022, listed Amgen among the companies defying demands for exit or reduction of activities.[3] In March 2022, Amgen donated $500,000 in disaster relief grants to International Medical Corps and Project Hope and provided matching funds for employee donations to select charities supporting humanitarian efforts in Ukraine.[4][5][6]
Thanks! Mary Gaulke (talk) 20:05, 23 May 2022 (UTC)[reply]
One more thought – would this be better incorporated into the "History" section rather than having its own section, per WP:CSECTION? Mary Gaulke (talk) 19:11, 24 May 2022 (UTC)[reply]
@Quetstar: Would love your feedback if you have a moment. Or, I can open up a new request. Thanks! Mary Gaulke (talk) 16:00, 2 June 2022 (UTC)[reply]
Sorry for the delay, I'm quite busy right now, so I am deferring this to other editors. As for the paragraph you proposed, it looks good IMO, but i think that a second opinion from a more experienced editor will do the trick. You're welcome to make a new request at any time. Quetstar (talk) 21:52, 2 June 2022 (UTC)[reply]
No problem – I'll open up a new request. Thanks for the reply! Mary Gaulke (talk) 21:39, 4 June 2022 (UTC)[reply]

References

  1. ^ Emerson, Jakob (15 April 2022). "US healthcare companies are still operating in Russia — others have left altogether". Becker's Hospital Review. Retrieved 17 May 2022.
  2. ^ Dunn, Catherine (11 March 2022). "U.S. pharma companies are staying in Russia as other industries exit". The Philadelphia Inquirer. Retrieved 17 May 2022.
  3. ^ "Over 750 Companies Have Curtailed Operations in Russia—But Some Remain". Yale School of Management. Retrieved 28 April 2022.
  4. ^ Bradway, Bob (3 March 2022). "Message from Amgen CEO Bob Bradway on Ukraine and Amgen Foundation Grant". Amgen. Retrieved 17 May 2022.
  5. ^ "Pharmaceutical industry response to the war in Ukraine". European Federation of Pharmaceutical Industries and Associations. 10 March 2022. Retrieved 17 May 2022.
  6. ^ Kansteiner, Fraiser (20 April 2022). "AbbVie joins roster of Big Pharmas donating Russian profits as war in Ukraine rages on". Fierce Pharma. Retrieved 17 May 2022.

COI Edit Request April 2023

Hi there! I have a COI: Amgen is a client of my employer, Porter Novelli. Requesting some edits to this article to provide a more complete reflection of the company's history as depicted in independent, reliable sources over the years.

Lead

  • Update the second mention of "Thousand Oaks, California" to just "Thousand Oaks" – not necessary to repeat the state two sentences in a row.
  • Update
Amgen's Thousand Oaks staff in 2017 numbered 5,125 (7.5% of total city employment) and included hundreds of scientists, making Amgen the largest employer in Ventura County.[1][2][3]
to
Amgen's Thousand Oaks staff in 2022 numbered approximately 5,000[4] (8.5% of total city employment)[5] and included hundreds of scientists, making Amgen the largest employer in Ventura County.[2][6] As of 2022, Amgen has approximately 24,000 staff[7] and, as of 2016, has a presence in approximately 100 countries. The company develops products in six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation.[8]
  • Delete
Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.[9]
Given that the source is more than 20 years old, I think it's fair to say this isn't the best representation of the organization's current goals.
  • Update
In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases.
to
In 2019, the company's largest selling products were Enbrel (etanercept),[10] a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases, and Neulasta (pegfilgrastim), an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy.[11]
  • Update
Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.
to include recent products, as follows:
Other marketed products include Evenity (romosozumab-aqqg), Otezla (apremilast), Prolia (denosumab), Repatha (evolocumab), and Lumakras (sotorasib).
  • Move
Amgen sponsored the Tour of California from 2011 to 2017.[12]
from the lead into the History section.

History

  • Move the following sentence from the intro into the history section as the first sentence:
Amgen was established in Thousand Oaks, California, in 1980.

Thank you for your time and assistance. JZindler (talk) 20:20, 17 April 2023 (UTC)[reply]

References

  1. ^ http://www.toaks.org/home/showdocument?id=17130 (Page 162).
  2. ^ a b Cite error: The named reference Baker, Pam 2002 Page 37 was invoked but never defined (see the help page).
  3. ^ "Biotech giant Amgen has big plans for new plant". Moorpark Acorn. 16 February 2018.
  4. ^ Biasotti, Tony (9 April 2022). "In Thousand Oaks, biotech execs discuss industry's 'rising tide,' lament area's lack of housing". Pacific Coast Business Times. Retrieved 19 September 2022.
  5. ^ "Annual Comprehensive Financial Report". City of Thousand Oaks, California. 30 June 2021. p. 156. Retrieved 19 September 2022.
  6. ^ "Biotech giant Amgen has big plans for new plant". Moorpark Acorn. 16 February 2018.
  7. ^ Talhelm, Matt (7 March 2022). "Amgen to offer workers an average salary of $119,510 at new facility". WRAL TechWire. Retrieved 20 September 2022.
  8. ^ "Form 10-K". U.S. Securities and Exchange Commission.
  9. ^ Bidwell, Carol A. (1989). The Conejo Valley: Old and New Frontiers. Windsor Publications. Pages 128–129. ISBN 9780897812993.
  10. ^ Blankenship, Kyle (27 July 2020). "The top 20 drugs by global sales in 2019". Fierce Pharma. Retrieved 12 July 2022.
  11. ^ Hagen, Tony (4 February 2021). "Amgen Profits Get a Ride on Biosimilar Growth". The Center For Biosimilars. Retrieved 12 July 2022.
  12. ^ "AMGEN TOUR OF CALIFORNIA". Amgen Tour of California. Archived from the original on 2020-02-04. Retrieved 2020-02-07.